Tango Therapeutics GAAP EPS of $0.13 beats by $0.14, revenue of $53.81M beats by $12.57M

3 hours ago 1

Tango Therapeutics press release (TNGX): Q3 GAAP EPS of $0.13 beats by $0.14.
Revenue of $53.81M (+363.5% Y/Y) beats by $12.57M.
As of September 30, 2025, the company held $152.8 million in cash, cash equivalents and marketable securities, in addition to $212.0 million in net proceeds from